Episode Summary
John shares our take on the first half of July, including CMS’s decision to green-light a Medicaid value-based drug plan, and how JJMDC added a collaboration with Mercy to its list of partnerships designed to improve patient care.
Episode Notes
John shares our take on the first half of July, including CMS’s decision to green-light a Medicaid value-based drug plan, and how JJMDC added a collaboration with Mercy to its list of partnerships designed to improve patient care.
- The Centers for Medicare and Medicaid Services (CMS) has approved the nation’s first value-based purchasing agreement for Medicaid, by approving Oklahoma’s request to allow the state to negotiate supplemental rebate agreements with drug manufacturers.
- Mercy announced a research collaboration with Johnson & Johnson Medical Devices Cos. (JJMDC). In a press release, JJMDC said it would utilize Mercy's data infrastructure to inform and improve regulatory decision making and health outcomes for medical devices.
About Darwin Research Group
Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.
CONNECT WITH US:
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn
📺 Watch Health Care Rounds on YouTube
⚙️ Health Care Rounds is produced by Grippi Media
Recommended Next
Subscribe to Our Take
Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.
